Here are relevant reports on : cell-based-assays-market
-
PVDF Membrane Market by Technology, Type (Hydrophobic, Hydrophilic), Application (General Filtration, Sample Preparation, Bead – Based Assays), End-Use Industry (Biopharmaceutical, Industrial, Food & Beverage), and Region - Global Forecast to 2027
The PVDF membrane market is expected to grow from USD 779 million in 2022 to USD 1,126 million by 2027, at a CAGR of 7.7% during the forecast period. The key players in this market are Arkema S.A. (France), Merck Millipore (US), KOCH Separation Solutions (US), Pall Corporation (US), Cytiva Life Science (US), CITIC Envirotech Pte Ltd (Singapore), Bio-Rad laboratories (US), Thermo Fisher Scientific Inc. (US), Membrane Solutions, LLC. (US), GVS Filter Technology (Italy), and Toray Industries, Inc. (Japan).
- Published: January 2023
- Price: $ 4950
- TOC Available:
-
Metabolism Assays Market Size, Share & Trends by Product (Instruments, Assays Kits), Technology (Colorimetry, Fluorimetry, Spectrometry), Application (Diagnostics (Diabetes, Obesity), Research), End User (Hospitals, Diagnostic Laboratories), & Region - Global Forecast to 2028
The global metabolism assays market, valued at US$1.3B in 2022, is forecasted to grow at a 7.8% CAGR, reaching US$1.4B by 2023 and US$2.1B by 2028. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Latin American Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application (Research, (Clinical- Cancer, Hematology), Industrial), End User (Biotech, Hospitals) - Forecast to 2027
The latin american flow cytometry market size is projected to reach USD 379 million by 2027, at a CAGR of 7.1% during the forecast period. Key players in this market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec GmbH (Germany), Cytek Biosciences, Inc. (US), and Luminex Corporation (US).
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Humanized Mouse and Rat Model Market by Type (Genetic Models, Cell-based Models, Rat Models), Application (Oncology, Immunology, Neuroscience, Toxicology, Infectious Diseases), End User (Pharma, Biotech), and Region - Global Forecast to 2030
The global humanized mouse and rat model market, valued at US$255.8M in 2024, is forecasted to grow at a 8.2% CAGR, reaching US$276.2M by 2025 and US$409.8M by 2030. The surge in the use of humanized models in drug discovery research, rising demand for personalized medicine, and increasing R&D activities in the pharmaceutical & biotechnology industry are contributing to market growth.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Aircraft Platforms Market by Type (Transport Aircraft, Special Missions Aircraft, UAVs), Power Source (Fuel Cell, SAF-Based, Battery-Powered), Propulsion Technology (Turbofan, Turfoprop, Turbojet, Electric), and Region - Global Forecast to 2030
The global aircraft platforms market size is expected to grow from USD 235.24 billion in 2024 to USD 301.19 billion by 2030, at a compound annual growth rate (CAGR) of 4.2% during the forecast period.The key players Airbus (France), Boeing (US), Embraer (Brazil), Textron Inc. (US), Lockheed Martin Corporation (US), General Dynamics (US), Northrop Grumman (US), Israel Aerospace Industries (Israel), Leonardo S.p.A (Italy), DJI (China), Bombardier (Canada), Ehang (China), ATR (France), General Atomics (US), Teledyne Flir LLC (US), Vertical Aerospace (UK), Archer Aviation (US), Dassault Aviation (France), and RTX (US).
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Healthcare Analytical Testing Services Market by Testing Type (Cell-based, Bioanalytical, Raw Material, Microbial, Stability, Batch-release, Genomic, Method Development & Validation), End User (Pharma, MedTech, Hospital), Region - Global Forecast to 2030
The global healthcare analytical testing services market, valued at US$6.33 billion in 2023, stood at US$7.48 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$12.48 billion by the end of the period. The key factors contributing to market growth include stringent regulatory guidelines, a growing focus on analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical and medical device companies, and the rising acceptance of a quality-by-design approach in pharmaceutical research and manufacturing.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Cancer Vaccines Market by Type (Preventive, Therapeutic (Neoantigen)), Technology (Cell-based Vaccine, Recombinant), Indication (Cervical, Prostate), ROA (Intramuscular, Intravenous), End User (Hospitals, Speciality Clinics) - Global Forecast to 2032
The global cancer vaccines market, valued at US$9.70 billion in 2023, stood at US$9.84 billion in 2024 and is projected to advance at a resilient CAGR of 5.4% from 2024 to 2032, culminating in a forecasted valuation of US$15.00 billion by the end of the period. The cancer vaccines market is growing rapidly, fueled by rising prevalence of cancer, technological advancements in immunotherapy, and increasing adoption of preventive healthcare across the globe.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Protein Labeling Market by Product (Reagents, Kits, & Services), Labeling Method (In Vitro Labeling, In Vivo Labeling), Application (Cell-Based Assay, Fluorescence Microscopy, Immunological Technique), & Region - Global Forecast to 2020
The protein labeling market is expected to reach USD 1,894.5 Million by 2020 from USD 1,089.5 Million in 2015, at a CAGR of 11.7%. Protein labeling is carried out using labeling reagents and kits to label an antibody or other protein, to make a fluorescent probe, enzyme conjugate, biotinylated binding reagent, or iodine-labeled tracer for detecting proteins in tissues, cells, and biochemical assays.
- Published: December 2015
- Price: $ 4950
- TOC Available:
-
Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines), Application (Research, Clinical, Cell Tissue & Banking), End User, Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2028
The global stem cell manufacturing market, valued at US$12.0 billion in 2022, stood at US$12.7 billion in 2023 and is projected to advance at a resilient CAGR of 11.3% from 2023 to 2028, culminating in a forecasted valuation of US$21.8 billion by the end of the period. The major factors driving the growth of this market are technological advancements in stem cell manufacturing and the increasing prevalence of genetic disorders, both of which are expected to propel market growth.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User - Global Forecast to 2029
The global cell expansion market, valued at US$12.7 billion in 2023, stood at US$14.3 billion in 2024 and is projected to advance at a resilient CAGR of 13.3% from 2024 to 2029, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth of the cell expansion market can be attributed to factors such as the booming biopharmaceutical industry, increased investments in research and development for the advancement of biopharmaceutical industry, rising need of advanced biopharmaceuticals, and increasing GMP certification for cell therapy manufacturing facilities.
- Published: March 2024
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
